Alloy Therapeutics

Wheeler Bio is a biomanufacturing company established in 2020 in Oklahoma City by Jesse McCool. The company focuses on accelerating the translation of therapeutic innovations into clinical applications through its biomanufacturing platform. By integrating pre-clinical discovery with biomanufacturing, Wheeler Bio aims to fill critical gaps between the discovery phase and early development. Its Portable CMC platform provides biopharma companies with rapid access to quality biomanufacturing, enabling a reliable pathway to clinical trials. This approach is designed to democratize access to comprehensive discovery-to-IND programs, making it easier for clients to navigate the complexities of bringing new therapies to market.

Wheeler Bio is a biomanufacturing company established in 2020 in Oklahoma City by Jesse McCool. The company focuses on accelerating the translation of therapeutic innovations into clinical applications through its biomanufacturing platform. By integrating pre-clinical discovery with biomanufacturing, Wheeler Bio aims to fill critical gaps between the discovery phase and early development. Its Portable CMC platform provides biopharma companies with rapid access to quality biomanufacturing, enabling a reliable pathway to clinical trials. This approach is designed to democratize access to comprehensive discovery-to-IND programs, making it easier for clients to navigate the complexities of bringing new therapies to market.

Vernal Biosciences is an mRNA manufacturing company that offers high-purity mRNA for both research and clinical applications. The company utilizes advanced processing and analytical methods to streamline the manufacturing process, significantly reducing development cycles typical in the advanced therapeutics sector. By providing high-quality mRNA and lipid nanoparticles (LNP-mRNA), Vernal Biosciences enables researchers to conduct drug discovery and development with flexibility, minimizing the need for substantial investment in proprietary teams and facilities. Its services cater to a wide range of mRNA-based life science needs, supporting both animal and human applications.

Tegmine Therapeutics is a private, seed-stage biotechnology company focused on developing antibody-based therapeutics aimed at treating cancer and tumors. The company utilizes a unique platform that integrates biology, mass spectrometry, and machine learning to identify proteins with specific modifications related to tumors. This approach targets disease-related glycan modifications that contribute to cancer progression and severity. By concentrating on these tumor-specific proteins, Tegmine Therapeutics seeks to enable the development of next-generation antibody drugs that offer greater specificity, thereby minimizing damage to healthy tissues during treatment.

Mytide Therapeutics specializes in the development of peptide-based solutions aimed at addressing challenges in the synthesis and purification of specific peptide classes. The company collaborates with partners to explore peptide modifications and create comprehensive peptide libraries. Mytide leverages advanced biopolymer fabrication technology, incorporating predictive analytics and machine learning to enhance the production and discovery of synthetic biomolecules. This innovative approach aims to accelerate the development of biological therapeutics for patients suffering from serious illnesses, including metabolic disorders, cancer, and inflammatory conditions. Additionally, Mytide offers a cloud platform that allows partners to easily order peptides, track orders, and access interactive data displays.

Wheeler Bio is a biomanufacturing company established in 2020 in Oklahoma City by Jesse McCool. The company focuses on accelerating the translation of therapeutic innovations into clinical applications through its biomanufacturing platform. By integrating pre-clinical discovery with biomanufacturing, Wheeler Bio aims to fill critical gaps between the discovery phase and early development. Its Portable CMC platform provides biopharma companies with rapid access to quality biomanufacturing, enabling a reliable pathway to clinical trials. This approach is designed to democratize access to comprehensive discovery-to-IND programs, making it easier for clients to navigate the complexities of bringing new therapies to market.

deepCDR Biologics AG is a biotechnology company based in Basel, Switzerland, founded in 2018. The company specializes in antibody optimization and discovery services, utilizing advanced technologies to deliver scalable solutions for its clients. By focusing on the development of innovative biologics, deepCDR Biologics aims to enhance the effectiveness of therapeutic antibodies in the pharmaceutical industry.

Wheeler Bio is a biomanufacturing company established in 2020 in Oklahoma City by Jesse McCool. The company focuses on accelerating the translation of therapeutic innovations into clinical applications through its biomanufacturing platform. By integrating pre-clinical discovery with biomanufacturing, Wheeler Bio aims to fill critical gaps between the discovery phase and early development. Its Portable CMC platform provides biopharma companies with rapid access to quality biomanufacturing, enabling a reliable pathway to clinical trials. This approach is designed to democratize access to comprehensive discovery-to-IND programs, making it easier for clients to navigate the complexities of bringing new therapies to market.

Vernal Biosciences is an mRNA manufacturing company that offers high-purity mRNA for both research and clinical applications. The company utilizes advanced processing and analytical methods to streamline the manufacturing process, significantly reducing development cycles typical in the advanced therapeutics sector. By providing high-quality mRNA and lipid nanoparticles (LNP-mRNA), Vernal Biosciences enables researchers to conduct drug discovery and development with flexibility, minimizing the need for substantial investment in proprietary teams and facilities. Its services cater to a wide range of mRNA-based life science needs, supporting both animal and human applications.